Raymond James & Associates’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $151M | Buy |
|
|||||
|
2024
Q2 | $146M | Sell |
|
|||||
|
2024
Q1 | $133M | Sell |
|
|||||
|
2023
Q4 | $139M | Buy |
|
|||||
|
2023
Q3 | $119M | Buy |
|
|||||
|
2023
Q2 | $117M | Sell |
|
|||||
|
2023
Q1 | $109M | Sell |
|
|||||
|
2022
Q4 | $108M | Buy |
|
|||||
|
2022
Q3 | $105M | Buy |
|
|||||
|
2022
Q2 | $102M | Sell |
|
|||||
|
2022
Q1 | $109M | Sell |
|
|||||
|
2021
Q4 | $100M | Buy |
|
|||||
|
2021
Q3 | $79.7M | Buy |
|
|||||
|
2021
Q2 | $62.1M | Sell |
|
|||||
|
2021
Q1 | $66.8M | Buy |
|
|||||
|
2020
Q4 | $67.2M | Buy |
|
|||||
|
2020
Q3 | $75M | Sell |
|
|||||
|
2020
Q2 | $80.3M | Buy |
|
|||||
|
2020
Q1 | $58M | Sell |
|
|||||
|
2019
Q4 | $76.4M | Sell |
|
|||||
|
2019
Q3 | $61.8M | Sell |
|
|||||
|
2019
Q2 | $69.9M | Sell |
|
|||||
|
2019
Q1 | $72.9M | Sell |
|
|||||
|
2018
Q4 | $66.6M | Sell |
|
|||||
|
2018
Q3 | $81.9M | Buy |
|
|||||
|
2018
Q2 | $70M | Sell |
|
|||||
|
2018
Q1 | $69.8M | Buy |
|
|||||
|
2017
Q4 | $61.1M | Buy |
|
|||||
|
2017
Q3 | $61.7M | Buy |
|
|||||
|
2017
Q2 | $47.1M | Buy |
|
|||||
|
2017
Q1 | $37.1M | Buy |
|
|||||
|
2016
Q4 | $22.8M | Sell |
|
|||||
|
2016
Q3 | $28.3M | Buy |
|
|||||
|
2016
Q2 | $27.1M | Buy |
|
|||||
|
2016
Q1 | $24.8M | Buy |
|
|||||
|
2015
Q4 | $37.7M | Buy |
|
|||||
|
2015
Q3 | $29.1M | Sell |
|
|||||
|
2015
Q2 | $35.4M | Buy |
|
|||||
|
2015
Q1 | $29.7M | Buy |
|
|||||
|
2014
Q4 | $25.3M | Buy |
|
|||||
|
2014
Q3 | $17.3M | Buy |
|
|||||
|
2014
Q2 | $13.5M | Buy |
|
|||||
|
2014
Q1 | $8.47M | Buy |
|
|||||
|
2013
Q4 | $8.48M | Buy |
|
|||||
|
2013
Q3 | $7.14M | Sell |
|
|||||
|
2013
Q2 | $7.59M | Buy |
|